Displaying 61 - 80 of 109
Statement of the Federal Trade Commission in the matter of Roche Holding/Spark Therapeutics
Date
By
Joseph J. Simons, Former Chairman;
Noah Joshua Phillips, Former Commissioner;
Rohit Chopra, Former Commissioner;
Rebecca Kelly Slaughter, Commissioner;
Christine S. Wilson, Former Commissioner
Matter Number
191 0086
Federal Trade Commission Closes Investigation of Roche Holding AG’s Proposed Acquisition of Spark Therapeutics, Inc.
Date
The Federal Trade Commission has closed its investigation into Roche Holding AG’s proposed acquisition of Spark Therapeutics, Inc. According to a Commission Statement, after an exhaustive, 10-month...
FTC Requires Bristol-Myers Squibb Company and Celgene Corporation to Divest Psoriasis Drug Otezla as a Condition of Acquisition
Date
Pharmaceutical and biologic manufacturers Bristol-Myers Squibb Company, or BMS, and Celgene Corporation have agreed to divest Celgene’s Otezla, the most popular oral treatment in the United States for...
Pharmaceutical Agreement Filing Procedures Updated
Date
The Federal Trade Commission is modernizing the process for filing agreements under the Medicare Prescription Drug, Modernization, and Improvements Act of 2003, or MMA, by requiring electronic filing...
FTC Staff Issues FY 2016 Report on Branded Drug Firms’ Patent Settlements with Generic Competitors
Date
A new Federal Trade Commission staff report found that, despite a considerable increase in the total number of final Hatch-Waxman patent settlements in FY 2016, significantly fewer settlements...
FTC Staff Comment to the FDA Department of Health and Human Services on Its Updated Guidance for Industry on the “Nonproprietary Naming of Biological Products”
Date
Matter Number
V190001
Docket Number
FDA-2013-D-1543
File
Text of the FTC Staff Comment
(52.95 KB)
FTC Submits Comment on FDA Guidance Regarding Nonproprietary Naming of Biological Products
Date
The Federal Trade Commission staff has responded to the Food and Drug Administration’s request for comment on its updated industry guidance regarding nonproprietary naming of biological products. The...
FTC Submits Comment on FDA Guidance Aimed at Deterring Abuse of Citizen Petition Process
Date
The Federal Trade Commission has responded to the Food and Drug Administration’s request for comment on its revised draft guidance, which aims to deter pharmaceutical companies from abusing the...
Federal Trade Commission Comment On the Food and Drug Administration’s Revised Draft Guidance For Industry, Entitled “Citizen Petitions and Petitions For Stay of Action Subject To Section 505(q) of the Federal Food, Drug, and Cosmetic Act.”
Date
Matter Number
P013510
Docket Number
FDA-2009-D-0008
File
FTC Submits Statement to HHS on Its Blueprint to Lower Drug Prices
Date
The Federal Trade Commission responded to the U.S. Department of Health and Human Services’ request for comment to its publication, Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs. The...
FTC Approves Final Order Imposing Conditions on Merger of Generic Drug Marketers Amneal Pharmaceuticals LLC and Impax Laboratories Inc.
Date
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Amneal’s $1.45 billion acquisition of an equity share in Impax likely would be...
Amneal Holdings and Impax Laboratories, In the Matter of
Type of Action
Administrative
Last Updated
FTC Matter/File Number
181 0017
C-4650
FTC Requires Generic Drug Marketers Amneal Pharmaceuticals LLC and Impax Laboratories Inc. to Divest Rights to 10 Generic Medications as Condition of Merger
Date
The Federal Trade Commission will require generic drug marketers Amneal Pharmaceuticals LLC and Impax Laboratories Inc. to divest Impax’s rights and assets for 10 products to three other companies, as...
FTC Staff Issues FY 2015 Report on Branded Drug Firms’ Patent Settlements with Generic Competitors
Date
The number of reverse-payment patent settlements entered into by pharmaceutical companies in fiscal year 2015 declined from fiscal year 2014, marking a second annual decrease in such settlements...
Displaying 61 - 80 of 109